BeOne Medicines Ltd (ONC)

• Market cap: $35.4B
• 1 day: -3.73%
• 5 days: 3.01%
• 1 month: -6.34%
• 3 months: 7.27%
• 6 months: 37.77%
• Year to date: 73.9%
• 1 year: 54.71%
• 5 years: 14.28%
• 10 years: 1,029.84%
• Sector: Healthcare
• Industry: Biotechnology

About: Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Employees: 11,000